Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells

Langmuir

Volumn 31, Issue 39, 2015, Pages 10764-10773

  Caracciolo, Giulio ^a   Palchetti, Sara ^a   Colapicchioni, Valentina ^b   Digiacomo, Luca ^a,c   Pozzi, Daniela ^a   Capriotti, Anna Laura ^d   La Barbera, Giorgia ^d   Laganà, Aldo ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c UNIVERSITY OF CAMERINO   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BINDING SITES; BINS; BIOCHEMISTRY; LIGHT SCATTERING; MACROPHAGES; MASS SPECTROMETRY; MOLECULAR BIOLOGY; NANOPARTICLES; PHYSIOLOGICAL MODELS; PROTEINS;

BIOMOLECULAR STRUCTURES; INTERFACIAL COMPOSITION; NANO LIQUID CHROMATOGRAPHY; NANOPARTICLE UPTAKES; PHYSIOLOGICAL RESPONSE; PROTEIN-BINDING SITES; SILICA NANOPARTICLES; TANDEM MASS SPECTROMETRY;

NANOSTRUCTURED MATERIALS;

NANOPARTICLE;

ADULT; ANIMAL; CELL LINE; ENDOCYTOSIS; HUMAN; LIQUID CHROMATOGRAPHY; MACROPHAGE; METABOLISM; MOUSE; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ADULT; ANIMALS; CELL LINE; CHROMATOGRAPHY, LIQUID; ENDOCYTOSIS; HUMANS; MACROPHAGES; MICE; NANOPARTICLES; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84942917287     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/acs.langmuir.5b02158     Document Type: Article

References (60)

1. Cedervall, T.; Lynch, I.; Foy, M.; Berggard, T.; Donnelly, S. C.; Cagney, G.; Linse, S.; Dawson, K. A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles Angew. Chem., Int. Ed. 2007, 46 (30) 5754-5756 10.1002/anie.200700465
2. Lynch, I.; Dawson, K. A. Protein-nanoparticle interactions Nano Today 2008, 3 (1) 40-47 10.1016/S1748-0132(08)70014-8
3. Lynch, I.; Salvati, A.; Dawson, K. A. Protein-nanoparticle interactions: what does the cell see? Nat. Nanotechnol. 2009, 4, 546-547 10.1038/nnano.2009.248
4. Walczyk, D.; Bombelli, F. B.; Monopoli, M. P.; Lynch, I.; Dawson, K. A. What the cell "sees" in bionanoscience J. Am. Chem. Soc. 2010, 132 (16) 5761-5768 10.1021/ja910675v
5. Salvati, A.; Pitek, A. S.; Monopoli, M. P.; Prapainop, K.; Bombelli, F. B.; Hristov, D. R.; Kelly, P. M.; Åberg, C.; Mahon, E.; Dawson, K. A. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface Nat. Nanotechnol. 2013, 8 (2) 137-143 10.1038/nnano.2012.237
6. Hajipour, M. J.; Laurent, S.; Aghaie, A.; Rezaee, F.; Mahmoudi, M. Personalized protein coronas: a "key" factor at the nanobiointerface Biomater. Sci. 2014, 2, 1210-1221 10.1039/C4BM00131A
7. Caracciolo, G.; Pozzi, D.; Capriotti, A. L.; Cavaliere, C.; Foglia, P.; Amenitsch, H.; Laganà, A. Evolution of the protein corona of lipid gene vectors as a function of plasma concentration Langmuir 2011, 27 (24) 15048-15053 10.1021/la202912f
8. Mahmoudi, M.; Laurent, S.; Shokrgozar, M. A.; Hosseinkhani, M. Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles ACS Nano 2011, 5 (9) 7263-7276 10.1021/nn2021088
9. Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Baldelli Bombelli, F.; Dawson, K. A. Physical- chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles J. Am. Chem. Soc. 2011, 133 (8) 2525-2534 10.1021/ja107583h
10. Amenitsch, H.; Caracciolo, G.; Foglia, P.; Fuscoletti, V.; Giansanti, P.; Marianecci, C.; Pozzi, D.; Laganà, A. Existence of hybrid structures in cationic liposome/DNA complexes revealed by their interaction with plasma proteins Colloids Surf., B 2011, 82 (1) 141-146 10.1016/j.colsurfb.2010.08.030
11. Tenzer, S.; Docter, D.; Rosfa, S.; Wlodarski, A.; Kuharev, J. r.; Rekik, A.; Knauer, S. K.; Bantz, C.; Nawroth, T.; Bier, C. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis ACS Nano 2011, 5 (9) 7155-7167 10.1021/nn201950e
12. Zhang, H.; Burnum, K. E.; Luna, M. L.; Petritis, B. O.; Kim, J. S.; Qian, W. J.; Moore, R. J.; Heredia-Langner, A.; Webb-Robertson, B. J. M.; Thrall, B. D. Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size Proteomics 2011, 11 (23) 4569-4577 10.1002/pmic.201100037
13. Mahmoudi, M.; Hosseinkhani, H.; Hosseinkhani, M.; Boutry, S.; Simchi, A.; Journeay, W. S.; Subramani, K.; Laurent, S. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine Chem. Rev. 2011, 111 (2) 253-280 10.1021/cr1001832
14. Vogler, E. A. Protein adsorption in three dimensions Biomaterials 2012, 33 (5) 1201-1237 10.1016/j.biomaterials.2011.10.059
15. Aggarwal, P.; Hall, J. B.; McLeland, C. B.; Dobrovolskaia, M. A.; McNeil, S. E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Adv. Drug Delivery Rev. 2009, 61 (6) 428-437 10.1016/j.addr.2009.03.009
16. Bargheer, D.; Nielsen, J.; Gébel, G.; Heine, M.; Salmen, S. C.; Stauber, R.; Weller, H.; Heeren, J.; Nielsen, P. The fate of a designed protein corona on nanoparticles in vitro and in vivo Beilstein J. Nanotechnol. 2015, 6 (1) 36-46 10.3762/bjnano.6.5
17. Papi, M.; Maulucci, G.; De Spirito, M.; Missori, M.; Arcovito, G.; Lancellotti, S.; Di Stasio, E.; De Cristofaro, R.; Arcovito, A. Ristocetin-induced self-aggregation of von Willebrand factor Eur. Biophys. J. 2010, 39 (12) 1597-1603 10.1007/s00249-010-0617-8
18. Pozzi, D.; Colapicchioni, V.; Caracciolo, G.; Piovesana, S.; Capriotti, A. L.; Palchetti, S.; De Grossi, S.; Riccioli, A.; Amenitsch, H.; Lagana, A. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells Nanoscale 2014, 6 (5) 2782-92 10.1039/c3nr05559k
19. Caracciolo, G.; Cardarelli, F.; Pozzi, D.; Salomone, F.; Maccari, G.; Bardi, G.; Capriotti, A. L.; Cavaliere, C.; Papi, M.; Lagana, A. Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/DNA nanoparticles ACS Appl. Mater. Interfaces 2013, 5 (24) 13171-9 10.1021/am404171h
20. Pearson, R. M.; Juettner, V. V.; Hong, S. Biomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery. Front. Chem. 2014, 2; DOI: 10.3389/fchem.2014.00108
21. Walkey, C. D.; Chan, W. C. W. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment Chem. Soc. Rev. 2012, 41 (7) 2780-2799 10.1039/C1CS15233E
22. Walkey, C. D.; Olsen, J. B.; Song, F.; Liu, R.; Guo, H.; Olsen, D. W. H.; Cohen, Y.; Emili, A.; Chan, W. C. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles ACS Nano 2014, 8 (3) 2439-2455 10.1021/nn406018q
23. Liu, R.; Jiang, W.; Walkey, C. D.; Chan, W. C.; Cohen, Y. Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties Nanoscale 2015, 7 (21) 9664-9675 10.1039/C5NR01537E
24. Caracciolo, G. Liposome-protein corona in a physiological environment: Challenges and opportunities for targeted delivery of nanomedicines Nanomedicine 2015, 11 (3) 543-557 10.1016/j.nano.2014.11.003
25. Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K. A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts Proc. Natl. Acad. Sci. U. S. A. 2008, 105 (38) 14265-70 10.1073/pnas.0805135105
26. Byrne, J. D.; Betancourt, T.; Brannon-Peppas, L. Active targeting schemes for nanoparticle systems in cancer therapeutics Adv. Drug Delivery Rev. 2008, 60 (15) 1615-26 10.1016/j.addr.2008.08.005
27. Mirshafiee, V.; Mahmoudi, M.; Lou, K.; Cheng, J.; Kraft, M. L. Protein corona significantly reduces active targeting yield Chem. Commun. 2013, 49 (25) 2557-9 10.1039/c3cc37307j
28. Monopoli, M. P.; Aberg, C.; Salvati, A.; Dawson, K. A. Biomolecular coronas provide the biological identity of nanosized materials Nat. Nanotechnol. 2012, 7 (12) 779-86 10.1038/nnano.2012.207
29. Arvizo, R. R.; Giri, K.; Moyano, D.; Miranda, O. R.; Madden, B.; McCormick, D. J.; Bhattacharya, R.; Rotello, V. M.; Kocher, J.-P.; Mukherjee, P. Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles PLoS One 2012, 7 (3) e33650 10.1371/journal.pone.0033650
30. Dixit, S.; Novak, T.; Miller, K.; Zhu, Y.; Kenney, M. E.; Broome, A.-M. Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors Nanoscale 2015, 7 (5) 1782-1790 10.1039/C4NR04853A
31. Ciasca, G.; Papi, M.; Chiarpotto, M.; Rodio, M.; Campi, G.; Rossi, C.; De Sole, P.; Bianconi, A. Transient state kinetic investigation of ferritin iron release Appl. Phys. Lett. 2012, 100 (7) 073703 10.1063/1.3685706
32. Lai, Z. W.; Yan, Y.; Caruso, F.; Nice, E. C. Emerging techniques in proteomics for probing nano-bio interactions ACS Nano 2012, 6 (12) 10438-48 10.1021/nn3052499
33. Capriotti, A. L.; Caracciolo, G.; Caruso, G.; Cavaliere, C.; Pozzi, D.; Samperi, R.; Lagana, A. Label-free quantitative analysis for studying the interactions between nanoparticles and plasma proteins Anal. Bioanal. Chem. 2013, 405 (2-3) 635-45 10.1007/s00216-011-5691-y
34. Zheng, T.; Pierre-Pierre, N.; Yan, X.; Huo, Q.; Almodovar, A. J.; Valerio, F.; Rivera-Ramirez, I.; Griffith, E.; Decker, D. D.; Chen, S. Gold Nanoparticle-Enabled Blood Test for Early Stage Cancer Detection and Risk Assessment ACS Appl. Mater. Interfaces 2015, 7 (12) 6819-6827 10.1021/acsami.5b00371
35. Smiley, S. T.; King, J. A.; Hancock, W. W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4 J. Immunol. 2001, 167 (5) 2887-2894 10.4049/jimmunol.167.5.2887
36. Mortensen, N. P.; Hurst, G. B.; Wang, W.; Foster, C. M.; Nallathamby, P. D.; Retterer, S. T. Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity Nanoscale 2013, 5 (14) 6372-6380 10.1039/c3nr33280b
37. Hadjidemetriou, M.; Al-Ahmady, Z.; Mazza, M.; Collins, R. F.; Dawson, K.; Kostarelos, K. In Vivo Biomolecule Corona around Blood-Circulating, Clinically-Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles ACS Nano 2015, 9, 8142 10.1021/acsnano.5b03300
38. Kelly, P. M.; Åberg, C.; Polo, E.; O'Connell, A.; Cookman, J.; Fallon, J.; Krpetić, Ž.; Dawson, K. A. Mapping protein binding sites on the biomolecular corona of nanoparticles Nat. Nanotechnol. 2015, 10, 472 10.1038/nnano.2015.47
39. Di Poto, A.; Papi, M.; Trivedi, S.; Maiorana, A.; Gavazzo, P.; Vassalli, M.; Lowy, F. D.; De Spirito, M.; Montanaro, L.; Imbriani, M. In vitro effect of temperature on the conformational structure and collagen binding of SdrF, a Staphylococcus epidermidis adhesin Appl. Microbiol. Biotechnol. 2015, 99, 5593 10.1007/s00253-015-6456-x
40. Caracciolo, G.; Caminiti, R. DNA-DNA electrostatic interactions within cationic lipid/DNA lamellar complexes Chem. Phys. Lett. 2004, 400, 314-319 10.1016/j.cplett.2004.10.134
41. Marchini, C.; Pozzi, D.; Montani, M.; Alfonsi, C.; Amici, A.; Amenitsch, H.; Candeloro De Sanctis, S.; Caracciolo, G. Tailoring lipoplex composition to the lipid composition of plasma membrane: a Trojan horse for cell entry? Langmuir 2010, 26 (17) 13867-73 10.1021/la1023899
42. Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Bombelli, F. B.; Dawson, K. A. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles J. Am. Chem. Soc. 2011, 133 (8) 2525-34 10.1021/ja107583h
43. Provencher, S. W. CONTIN: A general purpose constrained regularization program for inverting noisy linear algebraic and integral equations Comput. Phys. Commun. 1982, 27, 229-242 10.1016/0010-4655(82)90174-6
44. Barrán-Berdón, A. L.; Pozzi, D.; Caracciolo, G.; Capriotti, A. L.; Caruso, G.; Cavaliere, C.; Riccioli, A.; Palchetti, S.; Lagana, A. Time evolution of nanoparticle-protein corona in human plasma: Relevance for targeted drug delivery Langmuir 2013, 29 (21) 6485-6494 10.1021/la401192x
45. Searle, B. C. Scaffold: a bioinformatic tool for validating MS/MS-based proteomic studies Proteomics 2010, 10 (6) 1265-9 10.1002/pmic.200900437
46. Luck, M.; Paulke, B. R.; Schroder, W.; Blunk, T.; Muller, R. H. Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics J. Biomed. Mater. Res. 1998, 39 (3) 478-85 10.1002/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.3.CO;2-B
47. Caracciolo, G.; Callipo, L.; De Sanctis, S. C.; Cavaliere, C.; Pozzi, D.; Lagana, A. Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol-DOPE/DNA lipoplexes in serum Biochim. Biophys. Acta, Biomembr. 2010, 1798 (3) 536-43 10.1016/j.bbamem.2009.11.007
48. Tenzer, S.; Docter, D.; Kuharev, J.; Musyanovych, A.; Fetz, V.; Hecht, R.; Schlenk, F.; Fischer, D.; Kiouptsi, K.; Reinhardt, C.; Landfester, K.; Schild, H.; Maskos, M.; Knauer, S. K.; Stauber, R. H. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology Nat. Nanotechnol. 2013, 8 (10) 772-81 10.1038/nnano.2013.181
49. Capriotti, A. L.; Caracciolo, G.; Cavaliere, C.; Foglia, P.; Pozzi, D.; Samperi, R.; Laganà, A. Do plasma proteins distinguish between liposomes of varying charge density? J. Proteomics 2012, 75 (6) 1924-1932 10.1016/j.jprot.2012.01.003
50. Lesniak, A.; Fenaroli, F.; Monopoli, M. P.; Åberg, C.; Dawson, K. A.; Salvati, A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells ACS Nano 2012, 6 (7) 5845-5857 10.1021/nn300223w
51. Greco, E.; Santucci, M. B.; Sali, M.; De Angelis, F. R.; Papi, M.; De Spirito, M.; Delogu, G.; Colizzi, V.; Fraziano, M. Natural lysophospholipids reduce mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells Immunology 2010, 129 (1) 125-132 10.1111/j.1365-2567.2009.03145.x
52. Hu, W.; Peng, C.; Lv, M.; Li, X.; Zhang, Y.; Chen, N.; Fan, C.; Huang, Q. Protein corona-mediated mitigation of cytotoxicity of graphene oxide ACS Nano 2011, 5 (5) 3693-3700 10.1021/nn200021j
53. Chong, Y.; Ge, C.; Yang, Z.; Garate, J. A.; Gu, Z.; Weber, J. K.; Liu, J.; Zhou, R. Reduced Cytotoxicity of Graphene Nanosheets Mediated by Blood-Protein Coating ACS Nano 2015, 9, 5713-5724 10.1021/nn5066606
54. Waters, K. M.; Masiello, L. M.; Zangar, R. C.; Tarasevich, B. J.; Karin, N. J.; Quesenberry, R. D.; Bandyopadhyay, S.; Teeguarden, J. G.; Pounds, J. G.; Thrall, B. D. Macrophage responses to silica nanoparticles are highly conserved across particle sizes Toxicol. Sci. 2008, 107 (2) 553-569 10.1093/toxsci/kfn250
55. Tarallo, R.; Accardo, A.; Falanga, A.; Guarnieri, D.; Vitiello, G.; Netti, P.; D'Errico, G.; Morelli, G.; Galdiero, S. Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery Chem.-Eur. J. 2011, 17 (45) 12659-12668 10.1002/chem.201101425
56. Liu, Y.; Ji, M.; Wong, M. K.; Joo, K.-I.; Wang, P. Enhanced therapeutic efficacy of iRGD-conjugated crosslinked multilayer liposomes for drug delivery BioMed. Res. Int. 2013, 2013, 1-11 10.1155/2013/378380
57. Singh, L. P.; Bhattacharyya, S. K.; Kumar, R.; Mishra, G.; Sharma, U.; Singh, G.; Ahalawat, S. Sol-Gel processing of silica nanoparticles and their applications Adv. Colloid Interface Sci. 2014, 214, 17-37 10.1016/j.cis.2014.10.007
58. Herd, H. L.; Bartlett, K. T.; Gustafson, J. A.; McGill, L. D.; Ghandehari, H. Macrophage silica nanoparticle response is phenotypically dependent Biomaterials 2015, 53, 574-582 10.1016/j.biomaterials.2015.02.070
59. Walkey, C. D.; Olsen, J. B.; Guo, H.; Emili, A.; Chan, W. C. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake J. Am. Chem. Soc. 2012, 134 (4) 2139-2147 10.1021/ja2084338
60. Verhoef, J. J.; Carpenter, J. F.; Anchordoquy, T. J.; Schellekens, H. Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics Drug Discovery Today 2014, 19 (12) 1945-1952 10.1016/j.drudis.2014.08.015